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Introduction
Eosinophilic dermatosis of hematologic malignancy was first reported in 1965 and thought to be a hypersensitivity reaction to insect bites in patients with chronic lymphocytic leukemia (CLL) [1] . Subsequent reports noted that most patients failed to recall insect bites; thus, the term "insect bite-like reaction" was established [2] . Byrd The frequency of relapsing skin lesions was markedly reduced during periods in which the patient's hematologic malignancy was under better control. Recently, she had an exacerbation of her CLL and antineoplastic therapy was altered. Subsequently, she has had less frequent flares of her dermatosis after being placed on obinutuzumab.
eosinophilic dermatosis of myeloproliferative disease [3] , though Farber et al. favor the term eosinophilic dermatosis of hematologic malignancy to better encompass the numerous hematologic malignancies associated with this cutaneous eruption [4, 5] . We describe a woman with CLL whose lesions resembled varicella zoster virus infection and review the literature on eosinophilic dermatosis of hematologic malignancy. Her CLL therapy initially included fludarabine, cyclophosphamide, and rituximab but later included alemtuzumab, lenalidomide, venetoclax, and obinutuzumab.
Case Report
She presented to the dermatologist for evaluation of a new onset of her skin lesions; these were similar to those that her oncologist had previously treated as varicella zoster virus leukin-4 and interleukin-5; this imbalance may lead to a proliferation of neoplastic B cells, which have been considered a major driver of the eruption [3, 4, 9] . This hypothesis is supported by the fact that interleukin-5 is the major eosinophilrecruiting cytokine [4] . Alternatively, it has been thought that neoplastic B cells drive a hypersensitivity reaction [3] .
Several therapeutic options to treat eosinophilic dermatosis of hematologic malignancy have been reported. They include antibiotics, antihistamines, chemotherapy, dapsone, interferon alpha, intravenous immunoglobulin, phototherapy, and radiation [2, 4, 10] . Though some patients report favorable responses to therapy, overall the results have been disappointing [4] . The poor response underscores the lack of clarity of this condition's pathogenesis [4] .
In regards to prognosis, eosinophilic dermatosis of hematologic malignancy may be associated with an aggressive course of CLL [4] ; our patient lends support to this observation, given her repeat recurrences of CLL. Reported complications in patients with CLL and eosinophilic dermatosis of hematologic malignancy include Richter transformation and malignant clone expansion [2, 10] . An underlying state of immunosuppression is postulated as the cause for these occurrences.
Conclusion
Our patient's recurrent skin lesions of eosinophilic dermatosis of hematologic malignancy were clinically interpreted by her oncologist to be varicella zoster virus infection because they were frequently dermatomal. However, the likelihood of over 20 episodes of herpes zoster would be unique and unexpected; hence, we were prompted to evaluate her skin lesions and exclude the diagnosis of either a viral infection or
Discussion
Patients with CLL usually present with eosinophilic dermatosis of hematologic malignancy between 40 to 60 years of age [4] . Table 1 offers a review of this condition . The eruption often occurs concurrently with or months to years after the diagnosis of the associated hematologic malignancy.
However, the condition has also been reported to present prior to the cancer diagnosis [4] .
Eosinophilic dermatosis of hematologic malignancy occurs most often with CLL. It has also been associated with acute lymphoblastic leukemia, acute monocytic leukemia, large cell lymphoma, mantle cell lymphoma, multiple myeloma, and myelofibrosis [4, 6, 7] .
Eosinophilic dermatosis of hematologic malignancy has a polymorphic presentation. The condition may manifest as erythema, papules, nodules, urticaria, or vesicles [4, 9] .
The eruption is usually indurated and erythematous but can also be tender [4] . The clinical differential diagnosis includes arthropod assault, dermatitis herpetiformis, drug reaction, eosinophilic cellulitis, eosinophilic folliculitis, infection, leukemia cutis, papular urticaria, scabies, and urticarial stage of bullous pemphigoid [4, 9] .
Histologically, this condition displays a superficial and deep dense perivascular infiltrate of lymphocytes and eosinophils [2, 4] . Vesicles or bullae may also present due to intraepidermal or subepidermal edema [4] . Flame figures in the dermis have also been reported [5] . 
